Heparin After Thrombolysis: Dosing and Monitoring Protocol
After thrombolytic therapy, stop heparin during the thrombolytic infusion, then restart with weight-based intravenous dosing without a bolus at maintenance rates (18 IU/kg/hour or approximately 1,300 IU/hour for a 70 kg patient), targeting an aPTT of 1.5-2.5 times control (45-75 seconds). 1, 2
Post-Thrombolysis Heparin Protocol
Immediate Management
The British Thoracic Society guidelines explicitly state: "Before treatment, stop heparin; after treatment, use maintenance dose" 1. This critical instruction prevents excessive bleeding risk from combining full-dose heparin with active thrombolytic agents.
Dosing Regimen
Weight-based dosing (preferred):
- No bolus after thrombolysis
- Start at 18 IU/kg/hour continuous infusion 1, 2
- Alternative: Standard dosing at 1,300 IU/hour 1
Standard dosing (if weight-based unavailable):
- 1,300 IU/hour continuous infusion 1
- Adjust based on aPTT monitoring
The FDA label confirms therapeutic anticoagulation requires 20,000-40,000 units/24 hours (approximately 833-1,667 units/hour), but post-thrombolysis dosing should start conservatively at the lower maintenance range 2.
Monitoring Protocol
aPTT Monitoring Schedule:
- First check: 4-6 hours after starting heparin infusion 1, 2
- After dose adjustments: 6-10 hours later 1
- Once therapeutic: Daily 1
Target aPTT: 1.5-2.5 times control (typically 45-75 seconds) 1, 3, 2
Dose Adjustment Algorithm
The European Society of Cardiology provides a validated weight-based nomogram 3:
| aPTT Result | Action |
|---|---|
| <35 seconds (<1.2× control) | 80 U/kg bolus; increase rate by 4 U/kg/h |
| 35-45 seconds (1.2-1.5× control) | 40 U/kg bolus; increase rate by 2 U/kg/h |
| 46-70 seconds (1.5-2.3× control) | No change (therapeutic) |
| 71-90 seconds (2.3-3.0× control) | Reduce rate by 2 U/kg/h |
| >90 seconds (>3.0× control) | Stop for 1 hour, then reduce rate by 3 U/kg/h |
Additional Monitoring
Baseline laboratory tests 4:
- Complete blood count
- Platelet count
- Renal and hepatic function
- PT/INR
- aPTT
Ongoing monitoring 2:
- Platelet count every 2-3 days for first 14 days (heparin-induced thrombocytopenia surveillance)
- Hemoglobin/hematocrit every 2-3 days initially
- Then every 2 weeks or as clinically indicated
Critical Pitfalls to Avoid
1. Giving a Bolus Immediately Post-Thrombolysis
The guidelines are explicit: restart at maintenance dose only, without bolus 1. A bolus significantly increases bleeding risk when residual thrombolytic activity persists.
2. Inadequate Initial Dosing
Studies show that 29% of patients remain subtherapeutic at 24 hours and 46% at 48 hours with standard protocols 5. Weight-based dosing improves therapeutic achievement.
3. Infrequent aPTT Monitoring
The first 24-48 hours are critical. Check aPTT at 4-6 hours initially, not waiting until the next morning 2, 5.
4. Using Subcutaneous Heparin Post-Thrombolysis
Fixed-dose subcutaneous heparin (12,500 IU twice daily) produces highly variable anticoagulation with circadian patterns, leaving many patients subtherapeutic 6. Intravenous administration is strongly preferred post-thrombolysis.
5. Ignoring Renal Function
Patients with creatinine clearance <30 mL/min require dose reduction and more frequent monitoring, or consideration of alternative anticoagulation 4, 7.
Duration and Transition
Continue heparin for at least 5 days AND until INR ≥2.0 for 2 consecutive days if transitioning to warfarin 1, 3, 2. The European guidelines confirm that 5-7 days of heparin is as effective as 10-14 days when followed by adequate oral anticoagulation 3.
Warfarin overlap:
- Start warfarin on day 1 (5-10 mg daily) 1
- Continue heparin until INR 2.0-3.0 for 2 consecutive days 1, 2
- Discontinue heparin after 5 days minimum 1, 3
Special Considerations
For pulmonary embolism specifically, the same post-thrombolysis heparin protocol applies, though the British Thoracic Society guidelines were developed primarily for PE management 1.
Alternative to UFH: Low-molecular-weight heparin (LMWH) is preferred over unfractionated heparin for most VTE treatment due to more predictable pharmacokinetics and lower bleeding rates 4, 8, 9, but after thrombolysis, the transition protocol requires careful timing and LMWH should only be started once thrombolytic effects have dissipated (typically 12-24 hours post-thrombolysis).